This article has Open Peer Review reports available.
Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study
© The Author(s). 2017
Received: 6 December 2016
Accepted: 19 July 2017
Published: 9 August 2017
Open Peer Review reports
Pre-publication versions of this article are available by contacting email@example.com.
|6 Dec 2016||Submitted||Original manuscript|
|19 Jan 2017||Reviewed||Reviewer Report - Patricia Coyle|
|12 Apr 2017||Reviewed||Reviewer Report - Francesco Patti|
|16 May 2017||Author responded||Author comments - Frank A. Hoffmann|
|Resubmission - Version 2|
|16 May 2017||Submitted||Manuscript version 2|
|27 Jun 2017||Reviewed||Reviewer Report - Diane L. Cookfair|
|14 Jul 2017||Author responded||Author comments - Frank A. Hoffmann|
|Resubmission - Version 3|
|14 Jul 2017||Submitted||Manuscript version 3|
|19 Jul 2017||Editorially accepted|
|9 Aug 2017||Article published||10.1186/s12883-017-0928-9|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.